Moneycontrol
HomeWorldEmerging bat virus in China shows signs of another pandemic, scientists warn it's 'just a step away'
Trending Topics

Emerging bat virus in China shows signs of another pandemic, scientists warn it's 'just a step away'

Unlike SARS-CoV-2, the virus responsible for COVID-19, MERS outbreaks have been relatively contained but far more lethal, particularly in hospital settings.

June 06, 2025 / 19:17 IST
Story continues below Advertisement

Representational Image

A group of little-known bat viruses may be dangerously close to acquiring the ability to infect humans, raising alarms among virologists about the next potential spillover event. According to a new study published in the peer-reviewed journal Nature Communications, researchers in the United States have found that these viruses, which are closely related to the deadly MERS coronavirus, might need only a tiny genetic change to pose a serious threat to human health.

The viruses belong to a lesser-known subgroup of coronaviruses called merbecoviruses, a group that includes Middle East Respiratory Syndrome coronavirus (MERS-CoV). First detected in 2012, MERS-CoV is known for causing severe respiratory illness and carries a high fatality rate of around 34%. Unlike SARS-CoV-2, the virus responsible for COVID-19, MERS outbreaks have been relatively contained but far more lethal, particularly in hospital settings.

Story continues below Advertisement

Now, scientists from Washington State University, Caltech, and the University of North Carolina are warning that a specific cluster within the merbecovirus family may be approaching a tipping point.

The study focused on a subgroup known as the HKU5 viruses, a lineage of bat coronaviruses that has largely flown under the radar of global surveillance and virological research. However, what the team discovered has triggered concern.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show